Invitae Corporation
NVTA
Rang in aandelen
#35707
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Aandeelprijs
$0.016
Laatst gesynchroniseerd: 2024-03-11
Marktkapitalisatie
$3.27M
Verandering (1 dag)
-5.33%
Verandering (1 jaar)
5,233.33%
Land
US
Handel Invitae Corporation (NVTA)
Categorie
Healthcare
Koersgeschiedenis voor Invitae Corporation (NVTA)
Hoogste slotkoers: $0.00 op 2024-08-01
Laagste slotkoers: $19.17 op 2015-02-01
Laagste slotkoers: $19.17 op 2015-02-01
Koersgeschiedenis van Invitae Corporation van 2015 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2024 | -99.95% |
| 2023 | -71.56% |
| 2022 | -86.50% |
| 2021 | -67.85% |
| 2020 | 194.07% |
| 2019 | 47.18% |
| 2018 | 31.94% |
| 2017 | 20.96% |
| 2016 | -6.63% |
| 2015 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $684.40 | 20.66% |
US
|
|
| $233.87 | 7.23% |
US
|
|
| $395.97 | 110.60% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $174.87 | 19.88% |
US
|
